Anavex® AUSTRALIA Pty Limited is looking for volunteers to participate in a clinical research study to examine the effects of their experimental therapy. Volunteers are important for the development of new therapies and advancing our understanding of Alzheimer’s. In this clinical research study volunteers will randomly receive either the study drug or placebo. This design will enable Anavex® to assess the effectiveness of the study drug. Participation in this clinical research study may last up to a year.
If you are interested in becoming a volunteer, or know someone who might, please click here to answer a few short questions.
Please review and answer the questions below to see if you, or someone you know, may qualify for participation in the Anavex® 2-73-004 clinical research study. All responses to these questions are anonymous and Anavex®AUSTRALIA Pty Limited. will not store any of your answers or information unless you give expressed permission to do so.
Anavex® AUSTRALIA Pty Limited. and its affiliates (the “Company”) is a clinical stage biopharmaceutical company engaged in the development of differentiated therapeutics for the treatment of neurodegenerative and neurodevelopmental diseases including drug candidates to treat Alzheimer’s disease, other central nervous system (“CNS”) diseases, pain and various types of cancer. Please visit us at www.anavex.com to learn more.